New Research Poster 4 (open)
New Research Posters Session 4

Friday, October 24, 2014: 9:30 AM-12:00 PM
 
4.1
An Animal Model Investigating Developmental Pathways to ADHD: Prenatal Stress Interacts With Genetic Vulnerability in Determining Hyperactivity, Working Memory, and Mesocortical Dopaminergic Circuitry
Hanna Stevens, MD, PhD Yale Child Study Center, New Haven, CT
Polona Jager Yale School of Medicine, New Haven, CT
Abigail J. Sawyer Yale Child Study Center, New Haven, CT
 
4.2
Anti-Dweys Antibodies in Children and Adolescents: Comparison Between Acute Psychiatric Inpatients, Children of Systemic Lupus Erythematosus (SLE) Mothers and Healthy Controls
Maria Gariup, MD Universidad de Barcelona, Barcelona Spain
Azucena Gonzalez, MD Hospital Clínic of Barcelona, Barcelona Spain
Carles Serra-Pag_s, MD, PhD Hospital Clinic Barcelona, Barcelona Spain
Astrid Morer, MD, PhD Hospital Clínic of Barcelona, Barcelona Spain
 
4.3
Behavioral, Neural and Endocrine Mechanisms of the Mother-to-Infant Transmission of Trauma Through Social Fear Learning
Jacek Debiec, MD, PhD University of Michigan, Ann Arbor, Ann Arbor, MI
Regina M. Sullivan, PhD Nathan S. Kline Institute for Psychiatric Research and New York University School of Medicine, New York, NY
 
4.4
Bringing Genomics to Child and Adolescent Psychiatry Research: A Pilot Study of Microarray Analysis in Dried Blood Spots
Andrea Danese, MD, PhD Institute of Psychiatry, King's College London, London United Kingdom
 
4.5
No Increase in Autism Associated Genetic Events in Children Conceived by Assisted Reproduction
Sean Ackerman, MD University of Vermont, Burlington, VT
 
4.8
Exercise and Adolescent Depression: Biomarkers of Metabolism and Sleep
Richard R. Dopp, MD University of Michigan, Ann Arbor, MI
Ann Mooney, MSW University of Michigan, Ann Arbor, MI
George Gettys, MD, MPH University of Michigan Health System, Ann Arbor, MI
Roseanne Armitage, PhD University of Michigan, Ann Arbor, MI
 
4.9
Investigating Brain Network Emergence and Connectivity Using Dynamic Coherence in Children With ADHD and Controls During Spatial Working Memory Task
Kelly Tung, BS University of California, Los Angeles, Los Angeles, CA
Iman Mohammad-Rezazadeh, PhD University of California, Los Angeles, Los Angeles, CA
Jennifer Levitt, MD University of California, Los Angeles, Los Angeles, CA
Sandra K. Loo, PhD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
 
4.10
Low Bone Mass Predicts Persistence of Depression in Adolescents
Chadi A. Calarge, MD University of Iowa, Iowa City, IA
Brandon D. Butcher, BS University of Iowa, Iowa City, IA
William H. Coryell, MD University of Iowa, Iowa City, IA
Jess G. Fiedorowicz, MD, PhD University of Iowa, Iowa City, IA
Trudy L. Burns, PhD University of Iowa, Iowa City, IA
 
4.12
Neuroinflammatory Markers in Pediatric Bipolar Disorder
Larissa C. Portnoff, BA University of California, Los Angeles, Los Angeles, CA
Casey Armstrong University of California, Los Angeles, Los Angeles, CA
Elizabeth C. Breen, PhD University of California, Los Angeles, Los Angeles, CA
Naomi I. Eisenberger, PhD University of California, Los Angeles, Los Angeles, CA
Michael R. Irwin, MD University of California, Los Angeles, Los Angeles, CA
David J. Miklowitz, PhD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
 
4.13
Rejection in Friendship: Neural and Psychological Correlates Among Children and Adolescents
Suman Baddam, MD Yale Child Study Center, New Haven, CT
Jessica Crawford Yale Child Study Center, New Haven, CT
Jia Wu Yale Child Study Center, New Haven, CT
Linda C. Mayes, MD Yale University School of Medicine, New Haven, CT
Michael J. Crowley, PhD Yale University School of Medicine, New Haven, CT
 
4.15
Developmental Aspects of Cortical Excitability and Inhibition in Depressed and Healthy Youth: An Exploratory Study
Paul Croarkin Mayo Clinic, Rochester, MN
Paul Nakonezny, PhD University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Charles Lewis, MD Mayo Clinic, Rochester, MN
Michael Zaccariello Mayo Clinic, Rochester, MN
John Huxsahl Mayo Clinic, Rochester, MN
Betsy D. Kennard, PsyD University of Texas Southwestern Medical Center, Dallas, TX
Graham J. Emslie, MD University of Texas Southwestern Medical Center at Dallas, Dallas, TX
 
4.16
Genetics of Early Onset Bipolar Disorder: A Preliminary Analysis From the Treatment of Early Age Mania (TEAM) Study and Mayo Clinic Bipolar Bank
Paul Croarkin Department of Psychiatry and Psychology, Mayo Cinic, Rochester, MN
Joan L. Luby, MD Washington University School of Medicine, St. Louis, MO
Matthew Simonson, PhD Mayo Clinic, Rochester, MN
Marin Veldic, MD Mayo Clinic, Rochester, MN
Paramjit T. Joshi, MD Children's National Medical Center, Washington, DC
Karen Dineen Wagner, MD, PhD University of Texas Medical Branch, Galveston, TX
John T. Walkup, MD Weill Cornell Medical College, New York, NY
Alfredo Cuellar Barboza, MD Mayo Clinic, Rochester, MN
Leah Casuto, MD Linder Center of Hope, Mason, OH
Susan McElroy, MD Linder Center of Hope, Mason, OH
Jennifer Geske, MS Mayo Clinic, Rochester, MN
Peter S. Jensen, MD The REACH Institute, New York, NY
Mark Frye, MD Mayo Clinic, Rochester, MN
Joanna Biernacka, PhD Mayo Clinic, Rochester, MN
 
4.17
Adolescent Behavioral and Neural Reward Processing Differentially Affected by the Interplay Between Plasticity Genes and Positive Environmental Influences
Jennifer S. Richards, MSC Radboud University Medical Center and Karakter Child and Adolescent Psychiatry University Center, Nijmegen Netherlands
Catharina A. Hartman, PhD University of Groningen, University Medical Center Groningen, Groningen Netherlands
Daniel von Rhein, MSC Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen Netherlands
Barbara Franke, PhD University Medical Center Nijmegen, Nijmegen Netherlands
Pieter J. Hoekstra, MD, PhD University of Groningen, University Medical Center Groningen, Groningen Netherlands
Dirk J. Heslenfeld, PhD VU University Amsterdam, Amsterdam Netherlands
Jaap Oosterlaan, PhD VU University Amsterdam, Amsterdam Netherlands
Alejandro Arias Vásquez, PhD Radboud University Medical Center, Nijmegen Netherlands
Jan K. Buitelaar, MD, PhD Radboud University Medical Center and Karakter Child and Adolescent Psychiatry University Center, Nijmegen Netherlands
 
4.18
Structural and Behavioral Characterization of Zebrafish Knockouts of the Autism Risk Gene, CNTNAP2
Ellen J. Hoffman, MD Yale School of Medicine, New Haven, CT
Joseph Fernandez, BA Yale University School of Medicine, New Haven, CT
Kate Turner, BS University College London, London United Kingdom
Steve Wilson, PhD University College London, London United Kingdom
Jason Rihel, PhD University College London, London United Kingdom
Antonio J. Giraldez, PhD Yale University, New Haven, CT
Matthew State, MD, PhD University of California, San Francisco, San Francisco, CA
 
4.19
The Involvement of Neurotrophin Genetic Variants in Autistic Spectrum Symptomatology
Amaia Hervas Zuñiga, PhD Hospital Universitari Mutua Terrassa - University of Barcelona, Terrassa Spain
Isabel Rueda, MD Hospital Sant Joan de Deu, Barcelona Spain
Ayhesa Ruiz Hospital Universitari Mutua Terrassa - University of Barcelona, Terrassa Spain
Marta Salgado, MD Hospital Universitari Mutua Terrassa - University of Barcelona, Terrassa Spain
Noemi Balmaña, PhD Hospital Universitari Mutua Terrassa - University of Barcelona, Terrassa Spain
Patricia Romaris, BS Hospital Universitari Mutua Terrassa - University of Barcelona, Terrassa Spain
Marta Ribases, PhD Hospital Vall d'Hebron, Barcelona Spain
Bru Cormand, PhD University of Barcelona, Barcelona Spain
MJ Arranz, PhD fmt, Terrassa Spain
 
4.21
Aberrant Activation Patterns During Sad and Happy Face Processing in Depressed Adolescents
Eva C. Henje Blom, MD University of California, San Francisco, San Francisco, CA
Colm G. Connolly, PhD University of California, San Francisco, San Francisco, CA
Tiffany C. Ho, PhD University of California, San Francisco, San Francisco, CA
Kaja Lewinn, ScD University of California, San Francisco, San Francisco, CA
Alan N. Simmons, PhD University of California, San Diego, La Jolla, CA
Tony Yang, MD, PhD University of California, San Francisco, San Francisco, CA
 
4.22
Abnormally Strong Frontostriatal Intrinsic Functional Connectivity in Adolescents With Anxiety
Julia Dorfman, MD National Institute of Mental Health, Bethesda, MD
Dana Rosen, BS National Institute of Health, Bethesda, MD
Brenda Benson, BS National Institute of Health, Bethesda, MD
Daniel Pine, MD National Institute of Mental Health, Bethesda, MD
Monique Ernst, MD National Institute of Health, Bethesda, MD
 
4.23
Anatomical Coupling and Individual Differences in Visuospatial Skills in a Developing Population as Assessed by the Benton Judgment of Line Orientation Task
Alexander Denker Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD
Nancy R. Lee, PhD Drexel University, Philadelphia, PA
Armin Raznahan, MD, PhD Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD
Liv Clasen, PhD Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD
Jay Giedd Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD
 
4.24
Arterial Spin Labeling: A New Method to Examine Mood States in Youth
Nina Mikita, BA King's College London, Institute of Psychiatry, London United Kingdom
Mitul A Mehta, MA, PhD King's College London, Institute of Psychiatry, London United Kingdom
Fernando O. Zelaya, PhD King's College London, Institute of Psychiatry, London United Kingdom
Argyris Stringaris, MD, MRCPsych, PhD King's College London, Institute of Psychiatry, London United Kingdom
 
4.25
Encompass: An Integrated Treatment Intervention for Adolescents With Co-Occurring Psychiatric and Substance Use Disorders
Paula Riggs, MD University of Colorado at Denver, Denver, CO
 
4.26
From Silence to Speech: A Group Cognitive Behavioral Therapy Program for Children With Selective Mutism
Suneeta Monga, MD University of Toronto, Toronto, ON
Brittany Rosenbloom, MSC University of Toronto, Toronto, ON
Sandra Mendlowitz, PhD University of Toronto, Toronto, ON
Azadeh Tanha, MSC University of Toronto, Toronto, ON
 
4.27
A 52-Week, Open-Label Study of Oral Olanzapine With a Randomized Behavioral Weight Intervention in Adolescents With Schizophrenia or Bipolar I Disorder
Holland C. Detke, PhD Lilly Research Laboratories, Indianapolis, IN
Melissa P. DelBello, MD, MS University of Cincinnati, Cincinnati, OH
John Landry, MS Eli Lilly and Company, Toronto, ON
Ralf W. Dittmann, MD Central Institute of Mental Health, Mannheim Germany
 
4.28
A Phase-2 Pharmacokinetic Study of a Modified Release Formulation of Dextroamphetamine Following Evening Administration to Adolescents and Children With ADHD
Declan Quinn, BA, FRCPC University of Saskatchewan, Royal University Hospital, Saskatoon, SK
Twyla Bode, RN Royal University Hospital, Saskatoon, SK
Norberto J. DeSousa, MA Ironshore Pharmaceuticals & Development, Inc., Grand Cayman Cayman Islands
Bev Incledon, PhD Ironshore Pharmaceuticals & Development, Inc., Grand Cayman Cayman Islands
Albert Agro, PhD Ironshore Pharmaceuticals & Development, Inc., Grand Cayman Cayman Islands
Angus McLean, PhD Ironshore Pharmaceuticals & Development, Inc., Grand Cayman Cayman Islands
 
4.31
Pharmacokinetic and Safety Evaluation of Lurasidone in Pediatric Patients With Psychiatric Disorders
Robert L. Findling, MD, MBA The Johns Hopkins University and Kennedy Kreiger Institute, Baltimore, MD
Yu-Yuan Chiu, PhD Sunovion Pharmaceuticals Inc., Fort Lee, NJ
Robert Silva, PhD Sunovion Pharmaceuticals Inc., Fort Lee, NJ
Robert Goldman, PhD Sunovion Pharmaceuticals Inc., Fort Lee, NJ
Fengbin Jin, PhD Sunovion Pharmaceuticals Inc., Fort Lee, NJ
Antony Loebel, MD Sunovion Pharmaceuticals Inc., Fort Lee, NJ
 
4.32
Challenges in the Implementation of a Multinational Pediatric Pharmacokinetics (PK) Study With a New Antidepressant
Robert L. Findling, MD, MBA The Johns Hopkins University and Kennedy Kreiger Institute, Baltimore, MD
Jonas Lundahl, MMBA, MSC, PhD Lundbeck Inc, Valby Denmark
Grace Chen, PhD Takeda Development Center Americas, Inc., Deerfield, IL
Philippe Auby, MD Lundbeck Inc, Issy les Moulineaux France
 
4.33
A Randomized Controlled Trial of Lisdexamfetamine in Parent—Child Dyads With ADHD
James Waxmonsky, MD Florida International University, Miami, FL
Daniel Waschbusch, PhD Penn State College of Medicine, Hershey, PA
Dara Babinski, MA Penn State College of Medicine, Hershey, PA
Hugh Humphery, MD Florida International University, Miami, FL
Junea Augustus, BS Florida International University, Miami, FL
 
4.34
Chemotherapy-Induced Changes in Mouse Brain Development
Ellen van der Plas, PhD The Hospital for Sick Children, Toronto, ON
Russell J. Schachar, MD, FRCP The Hospital for Sick Children, Toronto, ON
Shiny Ito, MD The Hospital for Sick Children, Toronto, ON
Shoshana Spring, MS Mouse Imaging Centre, Toronto, ON
Brian J. Nieman, PhD Mouse Imaging Centre, Toronto, ON
 
4.35
Evidence for Decreased SPECT 123I Iomazenil Binding in the Anterior Cingulate Cortex of Children With Anorexia Nervosa
Shinichiro Nagamitsu, MD Kurume University School of Medicine, Kurume Japan
Michiko Matsuoka Department of Psychiatry, Kurume University School of Medicine, Kurume Japan
Hiromi Chiba Department of Psychiatry, Kurume University School of Medicine, Kurume Japan
Shuichi Ozono Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume Japan
Hitoshi Tanigawa Department of Radiology, Kurume University School of Medicine, Kurume Japan
Yushiro Yamashita, MD Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume Japan
Masatoshi Ishibashi Department of Radiology, Kurume University School of Medicine, Kurume Japan
Paul Croarkin Department of Psychiatry and Psychology, Mayo Cinic, Rochester, MN
Toyojiro Matsuishi Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume Japan
 
4.36
Impact of Acute Aerobic Exercise on Cerebral Blood Flow in Adolescents With Bipolar Disorder
Antonette Scavone, BS Sunnybrook Health Sciences Centre, Toronto, ON
Benjamin I. Goldstein, MD, PhD Sunnybrook Health Sciences Centre, Toronto, ON
David Crane, MSC Sunnybrook Research Institute, Toronto, ON
Zahra Shirzadi, MEng Sunnybrook Research Institute, Toronto, ON
Brad Macintosh, PhD Sunnybrook Research Institute, Toronto, ON
 
4.37
Neural Correlates of Emotional Face Processing as a Function of Parental Expressed Emotion in Youth at High Risk for Bipolar Disorder
Patricia Walshaw, PhD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Casey Armstrong University of California, Los Angeles, Los Angeles, CA
Amy Garrett, PhD Stanford University School of Medicine, Stanford, CA
Victoria Cosgrove, PhD Stanford University, Redwood City, CA
Susan Y. Bookheimer, PhD University of California, Los Angeles, Los Angeles, CA
Kiki Chang, MD Stanford University School of Medicine, Stanford, CA
David J. Miklowitz, PhD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
 
4.38
Neural Correlates of Psychotherapy of Depression in Adolescents
Michael G Koelch, MD University Hospital of Ulm, Ulm Germany
Joana Straub, PhD University Hospital of Ulm, Ulm Germany
Paul L. Plener, MD University Hospital of Ulm, Ulm Germany
Nina Sproeber, PhD University Hospital of Ulm, Ulm Germany
Linda Sprenger University of Marburg, Marburg Germany
Georg Groen, PhD University Hospital of Ulm, Ulm Germany
Brigit Abler, MD University Hospital of Ulm, Ulm Germany
 
4.39
Neural Responses to Dynamic Emotional Faces in Unmedicated Adolescents With Depression
Tiffany C. Ho, PhD University of California, San Francisco, San Francisco, CA
Jing Wu, BS University of Seattle, Washington, Seattle, WA
Eva C. Henje Blom, MD Karolinska Institutet, Stockholm Sweden
Colm G. Connolly, PhD University of California, San Francisco, San Francisco, CA
Kaja Lewinn, ScD University of California, San Francisco, San Francisco, CA
Alan N. Simmons, PhD University of California, San Diego, La Jolla, CA
Tony Yang, MD, PhD University of California, San Francisco, San Francisco, CA
 
4.40
Resting State Functional Connectivity in ADHD: Does the Default Mode Network (DMN) Differentiate on Each Subtype?
Marisol Picado, PhD Fundació Clínic per a la Recerca Biomèdica, Barcelona Spain
Laia Gil, MSC Fundació Clínic per a la Recerca Biomèdica, Barcelona Spain
Anna Calvo, MSC Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona Spain
Marta García, MD Hospital Clínic i Provincial de Barcelona, Barcelona Spain
Rosa Nicolau, PsyD Hospital Clínic i Provincial de Barcelona, Barcelona Spain
Montserrat Vila, MD Hospital Clínic i Provincial de Barcelona, Barcelona Spain
Sara Lera, PhD Hospital Clínic i Provincial de Barcelona, Barcelona Spain
Jaime Moya, MD Hospital Clínic i Provincial de Barcelona, Barcelona Spain
 
4.41
Structural and Functional MRI Assessment of Children With Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)
Maisi L. Mayo, BA Stanford School of Medicine, San Mateo, CA
Amy Garrett, PhD Stanford University School of Medicine, Stanford, CA
Jennifer Pearlstein, BS Stanford School of Medicine, Menlo Park, CA
Meike Gugel Stanford School of Medicine, San Francisco, CA
Jennifer Frankovich, MD Stanford University, Palo Alto, CA
Kiki Chang, MD Stanford University School of Medicine, Stanford, CA
 
4.42
The Neuroanatomical Basis of Inattention: A Voxel-Based Morphometric Study
Laia Gil, MSC Fundació Clínic per a la Recerca Biomèdica, Barcelona Spain
Marisol Picado, PhD Fundació Clínic per a la Recerca Biomèdica, Barcelona Spain
Anna Calvo, MSC Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona Spain
Marta García, MD Hospital Clínic i Provincial de Barcelona, Barcelona Spain
Rosa Nicolau, PsyD Hospital Clínic i Provincial de Barcelona, Barcelona Spain
Montserrat Vila, MD Hospital Clínic i Provincial de Barcelona, Barcelona Spain
Sara Lera, PhD Hospital Clínic i Provincial de Barcelona, Barcelona Spain
Jaime Moya, MD Hospital Clínic i Provincial de Barcelona, Barcelona Spain
 
4.43
The Relationship of Impulsivity and Cortical Surface Area in Depressed and Non-Depressed Adolescents
Yuli Fradkin, MD Institute of Living, Hartford, CT
Michael C. Stevens, PhD Yale University School of Medicine, Olin Neuropsychiatry Research Center, The Institute of Living and Hartford Hospital, Hartford, CT
Sabin Khadka, MS Olin Neuropsychiatry Research Center, Hartford, CT
Katie Bessette, BA Olin Neuropsychiatry Research Center, Hartford, CT
 
4.44
Cost Savings Through Proper Use of Integrated Therapy and Psychopharmacology in a Community, Non-Profit Clinic
Thomas P. Tarshis, MD, MPH Bay Area Children's Association, San Jose, CA
Kristen C. Lavelle, BA Bay Area Children's Association, San Jose, CA
Sara B. Heron, MD Bay Area Children's Association, Oakland, CA
 
4.45
Glutathione-Glutamate Pathway as an Augmentative Pharmacological Target for Behavioral Management in Children With Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial of Adjunctive N-Acetylcysteine
Mehdi Farokhnia, MD Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Northridge, CA
Mohammad Ali Nikoo, MD Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, CA
Habibeh Yekehtaz, MD Cardiovascular Research Center, Tehran Heart Center, Tehran University of Medical Sciences, Northridge, CA
Amir Hossein Gougol, MD Tehran University of Medical Sciences, Los Gatos, CA
Negar I. Gougol, MD Tehran University of Medical Sciences, Los Gatos, CA
Shahin Akhondzadeh, PhD Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, CA
 
4.46
Guanfacine for Hyperactivity in Children With Autism Spectrum Disorders
Lawrence Scahill, MSN, PhD Emory University, Atlanta, GA
 
4.47
Lithium in the Acute Treatment of a Manic or Mixed Episode in Pediatric Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled Study
Adelaide S. Robb, MD Children's National Medical Center, Washington, DC
Nora McNamara, MD University Hospitals Case Medical Center, Cleveland, OH
Mani N. Pavuluri, MD University of Illinois at Chicago, Chicago, IL
Vivian Kafantaris, MD The Zucker Hillside Hospital and Hofstra North Shore-LIJ Health System, Glen Oaks, NY
Russell Scheffer, MD University of Kansas School of Medicine-Wichita, Wichta, KS
Jean A. Frazier, MD University of Massachusetts Medical School, Worcester, MA
Moira A. Rynn, MD Columbia University, New York, NY
Melissa P. DelBello, MD, MS University of Cincinnati, Cincinnati, OH
Robert A. Kowatch, MD, PhD The Ohio State Wexner Medical Center, Columbus, OH
Brieana Rowles, MA University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA
Jacqui Lingler, MA Case Western Reserve University, Cleveland, OH
Karen Martz, MS The EMMES Corporation, Rockville, MD
Ravinder Anand, PhD The EMMES Corporation, Rockville, MD
Traci Clemons, PhD The EMMES Corporation, Rockville, MD
Perdita Taylor-Zapata, MD Eunice Kennedy Shriver National Institute of Child Health and Human Development, Rockville, MD
Robert L. Findling, MD, MBA The Johns Hopkins University and Kennedy Kreiger Institute, Baltimore, MD
 
4.48
Longitudinal Prescribing Practices in a Community, Non-Profit, Multidisciplinary, Evidence-Based, Child Psychiatric Clinic
Kristen C. Lavelle, BA Bay Area Children's Association, San Jose, CA
Thomas P. Tarshis, MD, MPH Bay Area Children's Association, San Jose, CA
Sara B. Heron, MD Bay Area Children's Association, Oakland, CA
 
4.49
Randomized, Double-Blind, Placebo-Controlled Crossover-Trial With Omega-3 Fatty Acids in Autism Spectrum Disorders
Mara Parellada CIBERSAM, Instituto de Investigación Sanitaria Gregorio Marañón, IiSGM. Hospital General Universitario Gregorio Marañón., Madrid Spain
Cloe Llorente, MD Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, IiSGM, CIBERSAM. Madrid, Spain., Madrid Spain
Rosa Calvo, MD Hospital Clínic de Barcelona, CIBERSAM, Barcelona Spain
Silvia Gutierrez, MD Hospital Niño Jesús, Madrid Spain
Montserrat Graell Hospital Niño Jesús, Madrid Spain
Maria Alvarez, BS CIBERSAM, Madrid Spain
Maria Guisasola, PhD Hospital General Universitario Gregorio Marañon, Madrid Spain
Elena Dulin, PhD Hospital General Universitario Gregorio Marañon, Madrid Spain
Jose Romo, MSC Hospital General Universitario Gregorio Marañón., Madrid Spain
Maria Luisa Dorado, MD Hospital General Universitario Gregorio Marañon, Madrid Spain
Celso Arango, PhD Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid Spain
Carmen Moreno, PhD Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid Spain
 
4.50
Sentia: A Spanish Systematic Online Monitoring Registry for Children and Adolescents Treated With Antipsychotics: Results From a 2-Year, Naturalistic Follow-Up Study
Inmaculada Palanca-Maresca, MD Puerta de Hierro University Hospital, Madrid, Spain, Madrid Spain
Belén Ruiz-Antoran, MD Puerta de Hierro University Hospital, Madrid, Spain, Madrid Spain
Gustavo Centeno, MD Puerta de Hierro University Hospital, Madrid, Spain, Madrid Spain
Azul Forti-Buratti, MD Puerta de Hierro University Hospital, Madrid, Spain, Madrid Spain
Hilario Blasco-Fontecilla, PhD Puerta de Hierro University Hospital, Madrid, Spain, Madrid Spain
Cristina Avendaño-Sola, MD Puerta de Hierro University Hospital, Madrid, Spain, Madrid Spain
Christoph U. Correll, MD The Zucker Hillside Hospital, Glen Oaks, NY
 
4.51
Sleep Problems, ADHD, and Treatment With Methylphenidate and Atomoxetine
Mark A. Stein, PhD University of Washington, Seattle, WA
Michelle Garrison, PhD Seattle Children's Research Institute, Seattle, WA
Beth Krone, PhD Icahn School of Medicine at Mount Sinai, New York, NY
Jeffrey H. Newcorn, MD Icahn School of Medicine at Mount Sinai, New York, NY
 
4.53
Tolerability and Effectiveness of Aripiprazole, Quetiapine, and Risperidone in Youth With Autism Spectrum Disorders
Zainab Al-Dhaher Zucker Hillside Hospital and Hofstra North Shore-LIJ School of Medicine, Glen Oaks, NY
Sally Azzo, MD Zucker Hillside Hospital-LIJ, Glen Oaks, NY
Christoph U. Correll, MD Hofstra North Shore LIJ School of Medicine, Glen Oaks, NY
 
4.54
Trends in Clonidine and Guanfacine Rates of Polypharmacy in Youth
Jaswinder K. Ghuman, MD Community Care Behavioral Health Organization, Pittsburgh, PA
Irina Karpov, MS Community Care Behavioral Health Organization, Pittsburgh, PA
Meghna Parthasarathy, MS Community Care Behavioral Health Organization, Pittsburgh, PA
Shari L. Hutchison, MS Community Care Behavioral Health Organization, Pittsburgh, PA
Kim Castelnovo Community Care Behavioral Health Organization, Pittsburgh, PA
James M. Schuster, MD Community Care Behavioral Health Organization, Pittsburgh, PA
 
4.55
Trends in the Use of Antidepressants Among Youth Following Food and Drug Administration (FDA) Warnings
Nicholas Carson, MD, FRCPC Cambridge Health Alliance, Cambridge, MA
Ye Wang, MS Boston University, Boston, MA
Nilay Kafali, PhD Cambridge Health Alliance-Harvard Medical School, Somerville, MA
Benjamin Cook, PhD Cambridge Health Alliance, Somerville, MA
 
4.56
Effect of Internet Addiction Group Cognitive Behavioral Therapy Treatment on Adolescents With Internet Addiction and Symptoms of Anxiety or Depression
Min-Hyeon Park The Catholic University of Korea, St. Vincent Hospital, Suwon South Korea
Hong Seung Chul, MD The Catholic University of Korea, St. Vincent Hospital, Suwon South Korea
Yim Hyeon-Woo The Catholic University of Korea College of Medicine, Seoul South Korea

See more of: New Research Poster
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.